Last reviewed · How we verify
NCT04416685
A New Anatomical Classification of Portal Vein Location of Pancreas Tumors
NA trial testing primary repair in Pancreatic Neoplasm Malignant Head Primary in 43 participants. Completed in 1 May 2019.
1 October 2018
Quick facts
| Lead sponsor | Sisli Hamidiye Etfal Training and Research Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 43 |
| Start date | 1 May 2014 |
| Primary completion | 1 October 2018 |
| Estimated completion | 1 May 2019 |
Drugs / interventions tested
- primary repair
- segmental resection
- graft reconstruction
Conditions studied
- Pancreatic Neoplasm Malignant Head Primary — all drugs for Pancreatic Neoplasm Malignant Head Primary →
Sponsor
Sisli Hamidiye Etfal Training and Research Hospital
Who can join
18 and older, any sex, with Pancreatic Neoplasm Malignant Head Primary. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this retrospective study, we recorded the location of pancreatic tumors and relation/proximity to the portal vein. The surgical difficulty and requirement of additional interventions were also evaluated.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04416685
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of primary repair
Trials testing the same drug.
- NCT04957069 — Comparison of Surgical Outcomes Between Avulsion Fracture of the AT and Conventional ATR--a Retrospective Study · completed
Other Sisli Hamidiye Etfal Training and Research Hospital trials
Trials by the same sponsor.
- NCT07334002 — The Effects of Conventional Therapy on Tinnitus, Disability, and Quality of Life in Patients With Tinnitus · NA · not yet recruiting
- NCT07321041 — Effect of Delivery Time on Umbilical Cord Blood Gas Parameters in Cesarean Sections Under General and Spinal Anesthesia · recruiting
- NCT07476690 — Effect of rESWT Session Frequency on Spasticity and Function Assessed by Sonoelastography in Children With Cerebral Pals · NA · recruiting
- NCT07166614 — Dexmedetomidine vs Propofol in High-Risk ERCP Patients · NA · recruiting
- NCT07250243 — Turkish Validation and Reliability of the John Hopkins In-Room Independence Scale · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04416685 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sisli Hamidiye Etfal Training and Research Hospital
- Last refreshed: 11 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04416685.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing